Erlocip Erlotinib 100 Mg Tablets
3200 INR/Bottle
Product Details:
- Origin of Medicine India
- Salt Composition Erlotinib 100 mg
- Indication Treatment of advanced or metastatic non-small cell lung cancer and pancreatic cancer
- Pacakaging (Quantity Per Box) 30 Tablets
- Dosage Form Tablet
- Drug Type Allopathic
- Ingredients Erlotinib Hydrochloride
- Click to View more
X
Erlocip Erlotinib 100 Mg Tablets Price And Quantity
- 1 Bottle
- 3200 INR/Bottle
- 24 Months
- 'E' on one side, '100' on the other
- Cipla Pharmaceuticals
- Round
- Rash, diarrhea, loss of appetite, fatigue
- Erlocip 100 mg
- White
- Not for use during pregnancy or breastfeeding unless prescribed
- Oral
- Prescription Only
Erlocip Erlotinib 100 Mg Tablets Product Specifications
- Treatment of advanced or metastatic non-small cell lung cancer and pancreatic cancer
- 30 Tablets
- As directed by oncologist, typically 100 mg once daily
- Store at room temperature, away from moisture and light
- Erlotinib 100 mg
- Tablet
- Tablets
- Erlotinib Hydrochloride
- India
- 30 Tablets per Box
- Take on an empty stomach or as prescribed by physician
- Anti-cancer, Tyrosine Kinase Inhibitor
- Non-Small Cell Lung Cancer, Pancreatic Cancer
- Allopathic
- Adults
- 24 Months
- 'E' on one side, '100' on the other
- Cipla Pharmaceuticals
- Round
- Rash, diarrhea, loss of appetite, fatigue
- Erlocip 100 mg
- White
- Not for use during pregnancy or breastfeeding unless prescribed
- Oral
- Prescription Only
Product Description
Erlocip 100 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
Effective Cancer Treatment
Erlocip 100 mg is specifically recommended for the treatment of non-small cell lung cancer and pancreatic cancer. With Erlotinib Hydrochloride as its active salt, this anti-cancer tablet works by interfering with the growth of cancer cells, providing a targeted approach in managing advanced or metastatic cancer cases.
Directions for Safe Use
To achieve the best results and minimize risks, Erlocip tablets should be used strictly under medical supervision. The usual dose is 100 mg orally once a day, taken on an empty stomach or as prescribed by the physician. It is essential to follow the dosage schedule and doctor's instructions for optimal efficacy.
Safety and Storage Guidelines
Erlocip 100 mg should not be used during pregnancy or breastfeeding unless explicitly prescribed. Store the tablets at room temperature, away from direct light and moisture. Always keep the medication in its original packaging and out of reach of children to ensure safety.
FAQ's of Erlocip Erlotinib 100 Mg Tablets:
Q: How should Erlocip Erlotinib 100 mg Tablets be taken for best results?
A: Erlocip 100 mg should be taken exactly as prescribed by your oncologist, typically once daily on an empty stomach, at least one hour before or two hours after eating. Do not alter the dosage or schedule unless instructed by your healthcare provider.Q: What are the main benefits of using Erlocip 100 mg for cancer treatment?
A: Erlocip 100 mg contains Erlotinib Hydrochloride, a tyrosine kinase inhibitor that targets the pathways promoting cancer cell growth. This targeted action makes it beneficial for treating advanced non-small cell lung cancer and pancreatic cancer, potentially slowing disease progression.Q: When should Erlocip not be used?
A: Erlocip 100 mg should not be used during pregnancy or breastfeeding unless specifically prescribed by a doctor, as it may harm the baby. Inform your physician of any medical conditions or other medications you are taking before starting the treatment.Q: What side effects might occur with Erlocip 100 mg?
A: Some common side effects include skin rash, diarrhea, loss of appetite, and fatigue. If you experience severe or persistent side effects, contact your healthcare provider promptly for advice.Q: How should Erlocip tablets be stored to maintain their efficacy?
A: Store Erlocip 100 mg tablets at room temperature, away from moisture, heat, and direct light. Ensure they remain in their original packaging and are out of reach of children to prevent accidental ingestion.Q: Where is Erlocip 100 mg manufactured and who markets it?
A: Erlocip 100 mg is manufactured in India by Cipla Pharmaceuticals and marketed under the trade name Erlocip 100 mg. It is distributed in boxes containing 30 tablets for prescription use only.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
